Legend Biotech (LEGN) EPS (Basic) (QoQ) (2019 - 2025)

Legend Biotech (LEGN) EPS (Basic) (QoQ) (2019 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Genmab A 276,399.99 Bn 276,398.47 Bn 831.00 Mn
2 Akari Therapeutics 1,217.26 Bn 1,217.26 Bn -
3 BeOne Medicines 419.38 Bn 414.59 Bn 1.35 Bn
4 Vertex Pharmaceuticals 126.54 Bn 119.30 Bn 2.59 Bn
5 Pharming 110.17 Bn 110.12 Bn 65.80 Mn
6 Regeneron Pharmaceuticals 64.97 Bn 56.22 Bn 3.31 Bn
7 Argenx Se 56.44 Bn 56.44 Bn 1.18 Bn
8 Alnylam Pharmaceuticals 40.09 Bn 37.08 Bn 959.66 Mn
9 Revolution Medicines 37.15 Bn 37.15 Bn -
10 Legend Biotech 11.04 Bn 10.14 Bn 242.10 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 227,600,997.22%
Sep 30, 2025 -67.65%
Jun 30, 2025 1,350.84%
Mar 31, 2025 100.00%
Dec 31, 2024 -1,755,687,989.23%
Sep 30, 2024 580.00%
Jun 30, 2024 407.44%
Mar 31, 2024 100.00%
Dec 31, 2023 -5,657,242,118.01%
Sep 30, 2023 -87.20%
Jun 30, 2023 3,475.17%
Mar 31, 2023 20.19%
Dec 31, 2022 -100.16%
Sep 30, 2022 -100.00%
Jun 30, 2022 7,270,360,252.37%
Mar 31, 2022 100.00%
Dec 31, 2021 27.13%
Sep 30, 2021 -100.16%
Jun 30, 2021 80,683.39%
Mar 31, 2021 -38.91%